Renovo News
Most Popular Renovo Story
Juvista trial failure sends Renovo into tailspin
In a terse release, the UK's Renovo said a Phase III trial for Juvista in scar revision surgery did not meet primary or secondary endpoints. The company's stock plunged 75 percent on the news. And Read more...
Latest Headlines
- December 19, 2011
- August 30, 2011
- February 11, 2011
- September 17, 2009
- April 6, 2009
- April 18, 2008
- March 25, 2008
- March 4, 2008
- March 3, 2008
- January 10, 2008
- September 11, 2007
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
